1. Home
  2. CSTL vs FSBC Comparison

CSTL vs FSBC Comparison

Compare CSTL & FSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSTL
  • FSBC
  • Stock Information
  • Founded
  • CSTL 2007
  • FSBC 2002
  • Country
  • CSTL United States
  • FSBC United States
  • Employees
  • CSTL N/A
  • FSBC N/A
  • Industry
  • CSTL Medical Specialities
  • FSBC Banks
  • Sector
  • CSTL Health Care
  • FSBC Finance
  • Exchange
  • CSTL Nasdaq
  • FSBC Nasdaq
  • Market Cap
  • CSTL 558.7M
  • FSBC 581.0M
  • IPO Year
  • CSTL 2019
  • FSBC 2021
  • Fundamental
  • Price
  • CSTL $16.75
  • FSBC $28.97
  • Analyst Decision
  • CSTL Strong Buy
  • FSBC Buy
  • Analyst Count
  • CSTL 6
  • FSBC 4
  • Target Price
  • CSTL $38.33
  • FSBC $34.75
  • AVG Volume (30 Days)
  • CSTL 548.5K
  • FSBC 51.0K
  • Earning Date
  • CSTL 05-05-2025
  • FSBC 04-28-2025
  • Dividend Yield
  • CSTL N/A
  • FSBC 2.73%
  • EPS Growth
  • CSTL N/A
  • FSBC N/A
  • EPS
  • CSTL N/A
  • FSBC 2.27
  • Revenue
  • CSTL $347,083,000.00
  • FSBC $124,973,000.00
  • Revenue This Year
  • CSTL N/A
  • FSBC $26.96
  • Revenue Next Year
  • CSTL $1.80
  • FSBC $15.14
  • P/E Ratio
  • CSTL N/A
  • FSBC $12.96
  • Revenue Growth
  • CSTL 38.43
  • FSBC 11.14
  • 52 Week Low
  • CSTL $15.70
  • FSBC $21.72
  • 52 Week High
  • CSTL $35.84
  • FSBC $35.13
  • Technical
  • Relative Strength Index (RSI)
  • CSTL 34.74
  • FSBC 60.16
  • Support Level
  • CSTL $15.84
  • FSBC $28.92
  • Resistance Level
  • CSTL $17.49
  • FSBC $29.53
  • Average True Range (ATR)
  • CSTL 0.90
  • FSBC 1.13
  • MACD
  • CSTL -0.18
  • FSBC 0.19
  • Stochastic Oscillator
  • CSTL 22.73
  • FSBC 68.91

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

About FSBC Five Star Bancorp

Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.

Share on Social Networks: